NDC 85509-1032-01 - Omeprazole and Sodium Bicarbonate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85509-1032
- Requested NDC
- 85509-1032-01
- Package NDCs from labels
- 85509-1032-1, 85509-1032-3, 85509-1032-6, 85509-1032-01
- Manufacturer
- PHOENIX RX LLC
- Effective date
- 2025-07-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Omeprazole and Sodium Bicarbonate - PHOENIX RX LLC | PHOENIX RX LLC | 2025-07-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85509-1032-1 | Omeprazole and Sodium Bicarbonate | 15 in 1 BOTTLE | CAPSULE | 15 | 1 | |
| 85509-1032-3 | Omeprazole and Sodium Bicarbonate | 30 in 1 BOTTLE | CAPSULE | 30 | 1 | |
| 85509-1032-6 | Omeprazole and Sodium Bicarbonate | 60 in 1 BOTTLE | CAPSULE | 60 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 85509-1032-1 | EA - Each | 85509-1032 | 4c44b5b7-b0ac-484d-85f9-a17e3036fe01 | 1 | 2025-09-12 |
| 85509-1032-3 | EA - Each | 85509-1032 | 5b2a135a-edb3-4cde-a451-100ae6c39f73 | 1 | 2025-09-12 |
| 85509-1032-6 | EA - Each | 85509-1032 | 73130392-c1c3-4357-9318-162a7e2bbbf8 | 1 | 2025-09-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| good neighbor pharmacy omeprazole | OMEPRAZOLE | Amerisource Bergen | f9aab207-d309-49b5-b941-c2912b186583 | 2025-12-21 | Warnings | KG60484QX9 |
| Walgreens Lubricant | POLYETHYLENE GLYCOL 400, AND PROPYLENE GLYCOL | Walgreens | 21dfe061-4538-2061-e063-6394a90a6e73 | 2025-12-19 | Warnings | 6DC9Q167V3 |
| SODIUM BICARBONATE | SODIUM BICARBONATE | ProPharma Distribution | 3867f743-c2cf-a646-e063-6394a90a82e1 | 2025-12-18 | Warnings, Adverse reactions | 8MDF5V39QO |
| SinuCleanse | SODIUM BICARBONATE, SODIUM CHLORIDE | ASCENT CONSUMER PRODUCTS, INC. | beb842fa-2373-4f21-9631-ef20ee124584 | 2025-12-10 | Warnings | 8MDF5V39QO |
| All natural Saline Packets CareOne | SODIUM BICARBONATE, SODIUM CHLORIDE | FOODHOLD U.S.A. | e32f105d-65cd-8095-e053-2995a90a9b6b | 2025-12-10 | Warnings | 8MDF5V39QO |
| Omeprazole | OMEPRAZOLE | American Health Packaging | 205652e1-7fbc-4b6a-bbd6-2fd346d812df | 2025-12-10 | Warnings, Adverse reactions | KG60484QX9 |
| omeprazole | OMEPRAZOLE | Kroger Company | 015b1c8f-9d5b-4afc-a55c-1a731b5fc72a | 2025-12-08 | Warnings | KG60484QX9 |
| Alka-Seltzer Heartburn | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE (HEAT-TREATED) | Bayer HealthCare LLC. | 55158e50-0327-2043-e054-00144ff8d46c | 2025-12-04 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Extra Strength | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE, AND ASPIRIN | Bayer HealthCare LLC. | 49b73bd5-6465-05eb-e054-00144ff88e88 | 2025-12-04 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Gold | ALKA-SELTZER GOLD | Bayer HealthCare LLC. | 0824bedb-413b-2fa0-e054-00144ff88e88 | 2025-12-04 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Bayer HealthCare LLC. | 5be36a7f-7d1f-468d-9c29-92c8cd3ef1bc | 2025-12-04 | Warnings | 8MDF5V39QO |
| OMEPRAZOLE AND SODIUM BICARBONATE | OMEPRAZOLE AND SODIUM BICARBONATE | Aurohealth LLC | 88ad2e92-2228-49b2-bcee-1770fd30cb14 | 2025-12-04 | Warnings | 616539 KG60484QX9 8MDF5V39QO |
| Omeprazole | OMEPRAZOLE | QPharma, Inc. | f5dd5d63-1376-1ff7-e053-2a95a90a1d94 | 2025-12-03 | Warnings, Adverse reactions | KG60484QX9 |
| Omeprazole | OMEPRAZOLE | Redpharm Drug | 44f59d88-d401-950b-e063-6294a90a2a50 | 2025-12-02 | Warnings | KG60484QX9 |
| Omeprazole | OMEPRAZOLE | A-S Medication Solutions | 17ccdbe0-19c1-498d-8e81-578be549b4e5 | 2025-12-02 | Warnings, Adverse reactions | KG60484QX9 |
| Omeprazole | OMEPRAZOLE | QPharma, Inc. | f5dcf0b2-4fa2-023a-e053-2995a90a183a | 2025-12-01 | Warnings, Adverse reactions | KG60484QX9 |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Ajanta Pharma USA Inc. | bd84ca00-6352-4cb3-bce2-05f4a5005a94 | 2025-11-30 | Warnings, Adverse reactions | KG60484QX9 8MDF5V39QO |
| Omeprazole | OMEPRAZOLE | Quallent Pharmaceuticals Health LLC | 665e9877-85ac-fdb6-54ac-1c47941ceab8 | 2025-11-28 | Warnings, Adverse reactions | KG60484QX9 |
| Splash Pure PF | PROPYLENE GLYCOL | LABORATORIOS SOPHIA, S.A. DE C.V. | 40ad7ae5-1f2a-e3b1-e063-6294a90a6f84 | 2025-11-26 | Warnings | 6DC9Q167V3 |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Niagara Pharmaceuticals Inc. | 362a6b6d-862d-4322-87a8-5b3a07fbe174 | 2025-11-24 | Warnings | 6DC9Q167V3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.